Oxford BioDynamics Plc (AIM:OBD)
London
· Delayed Price · Currency is GBP · Price in GBX 0.250
-0.000 (-0.16%)
Mar 6, 2026, 1:58 PM GMT
Oxford BioDynamics Revenue
In the fiscal year ending September 30, 2025, Oxford BioDynamics had annual revenue of 1.10M GBP with 72.17% growth. Oxford BioDynamics had revenue of 508.00K in the half year ending September 30, 2025, with 75.17% growth.
Revenue
1.10M
Revenue Growth
+72.17%
P/S Ratio
9.80
Revenue / Employee
26.71K
Employees
41
Market Cap
10.73M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 1.10M | 459.00K | 72.17% |
| Sep 30, 2024 | 636.00K | 126.00K | 24.71% |
| Sep 30, 2023 | 510.00K | 356.00K | 231.17% |
| Sep 30, 2022 | 154.00K | -187.00K | -54.84% |
| Sep 30, 2021 | 341.00K | -115.00K | -25.22% |
| Sep 30, 2020 | Pro | Pro | Pro |
| Sep 30, 2019 | Pro | Pro | Pro |
| Sep 30, 2018 | Pro | Pro | Pro |
| Sep 30, 2017 | Pro | Pro | Pro |
| Sep 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Futura Medical | 7.93M |
| IXICO | 6.53M |
| Fusion Antibodies | 1.60M |
| CRISM Therapeutics | 25.00K |
| OptiBiotix Health | 1.15M |
| Aptamer Group | 1.20M |
| SkinBioTherapeutics | 4.64M |